Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-003526-32Phase 3Completed
Phase 3, randomised, double-blind trial of diclofenac in bruise (3 arms), sponsored by Fidia Farmaceutici. Primary endpoints: Non-inferiority objective and Superiority objective. Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-003526-32.